Collegium Pharmaceutical Inc (COLL)
35.84
+0.36
(+1.01%)
USD |
NASDAQ |
Apr 25, 16:00
35.85
+0.01
(+0.03%)
After-Hours: 20:00
Collegium Pharmaceutical Cash from Financing (TTM): -140.18M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -140.18M |
September 30, 2023 | -98.18M |
June 30, 2023 | -34.01M |
March 31, 2023 | -12.74M |
December 31, 2022 | 436.72M |
September 30, 2022 | 420.05M |
June 30, 2022 | 424.79M |
March 31, 2022 | 439.93M |
December 31, 2021 | -89.30M |
September 30, 2021 | -59.21M |
June 30, 2021 | -44.73M |
March 31, 2021 | -48.11M |
December 31, 2020 | 286.47M |
September 30, 2020 | 300.29M |
June 30, 2020 | 312.73M |
March 31, 2020 | 324.99M |
December 31, 2019 | 2.041M |
September 30, 2019 | -33.04M |
June 30, 2019 | -66.53M |
Date | Value |
---|---|
March 31, 2019 | -116.64M |
December 31, 2018 | -117.20M |
September 30, 2018 | -58.97M |
June 30, 2018 | -16.59M |
March 31, 2018 | 33.04M |
December 31, 2017 | 33.48M |
September 30, 2017 | 94.75M |
June 30, 2017 | 85.25M |
March 31, 2017 | 85.06M |
December 31, 2016 | 135.56M |
September 30, 2016 | 49.10M |
June 30, 2016 | 49.02M |
March 31, 2016 | 121.50M |
December 31, 2015 | 115.99M |
September 30, 2015 | 121.66M |
June 30, 2015 | 127.92M |
March 31, 2015 | 56.04M |
December 31, 2014 | 12.04M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-140.18M
Minimum
Dec 2023
439.93M
Maximum
Mar 2022
122.21M
Average
-12.74M
Median
Mar 2023
Cash from Financing (TTM) Benchmarks
Immunogen Inc (DELISTED) | 495.80M |
Supernus Pharmaceuticals Inc | -397.88M |
AnaptysBio Inc | -59.30M |
Recursion Pharmaceuticals Inc | 140.13M |
Nuvalent Inc | 336.85M |